Segment Information (Tables)

6 Months Ended

Dec. 31, 2017

Segment Reporting [Abstract]

Schedule of segment performance measures

Six months Ended December 31, 2017 and 2016:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2017
Net sales	$	209,481	$	70,205	$	76,798	$	-		$	356,484
Gross profit		47,545		10,221		16,187		-			73,953
Income (loss) before income taxes		7,314		2,808		7,422		(15,905	)		1,639
2016
Net sales	$	101,870	$	77,432	$	74,268	$	-		$	253,570
Gross profit		31,124		12,612		17,908		-			61,644
Income (loss) before income taxes		8,905		4,263		8,565		(15,887	)		5,846

Three months Ended December 31, 2017 and 2016:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2017
Net sales	$	103,466	$	33,629	$	34,134	$	-		$	171,229
Gross profit		22,898		4,381		6,691		-			33,970
Income (loss) before income taxes		2,288		577		2,477		(5,841	)		(499	)
2016
Net sales	$	53,981	$	36,816	$	34,755	$	-		$	125,552
Gross profit		16,919		5,658		8,228		-			30,805
Income (loss) before income taxes		4,933		1,196		3,733		(10,796	)		(934	)